UBS analyst Danielle Antalffy lowered the firm’s price target on Sight Sciences (SGHT) to $5 from $5.50 and keeps a Buy rating on the shares. Following conversations with management, the firm ...

Stifel lowered the firm’s price target on Sight Sciences (SGHT) to $4 from $5 and keeps a Buy rating on the shares. 2025 revenue guidance of $70M-$75M fell short of the firm’s latest $75M ...

Lake Street analyst Frank Takkinen lowered the firm’s price target on Sight Sciences (SGHT) to $2.50 from $3 and keeps a Hold rating on the shares. Glaucoma market-wide headwinds continue to ...

The depot is playing a key role in the rollout of the Family of Weapon Sights Individual, a lightweight thermal imaging ...

Morgan Stanley decreased their target price on Sight Sciences from $7.00 to $5.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Citigroup ...